StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS - Free Report) in a research report sent to investors on Sunday morning. The brokerage issued a hold rating on the stock.
Separately, Benchmark reissued a "speculative buy" rating and issued a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th.
Check Out Our Latest Report on MLSS
Milestone Scientific Stock Up 1.1 %
NYSE MLSS traded up $0.01 during trading hours on Friday, hitting $0.95. 89,455 shares of the stock were exchanged, compared to its average volume of 81,428. The company has a market cap of $74.00 million, a price-to-earnings ratio of -13.57 and a beta of 1.10. Milestone Scientific has a 12-month low of $0.52 and a 12-month high of $1.10. The stock has a 50-day moving average of $0.83 and a 200 day moving average of $0.87.
Insider Activity
In related news, Director Leonard Osser sold 107,984 shares of the company's stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the sale, the director now owns 4,606,882 shares in the company, valued at $4,284,400.26. This represents a 2.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 24.75% of the company's stock.
Institutional Trading of Milestone Scientific
Several large investors have recently bought and sold shares of MLSS. Geode Capital Management LLC boosted its position in shares of Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock worth $480,000 after buying an additional 31,572 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new position in Milestone Scientific during the third quarter worth about $48,000. Finally, World Investment Advisors LLC purchased a new stake in shares of Milestone Scientific in the third quarter valued at about $91,000. Institutional investors and hedge funds own 5.79% of the company's stock.
Milestone Scientific Company Profile
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Recommended Stories
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
